Venezuela’s state oil firm PDVSA has revoked multiple authorizations previously granted to Chevron (NYSE: CVX), halting the U.S. company's planned crude oil exports from Venezuela in April, according to three sources familiar with the matter. The move follows a tightening of U.S. sanctions and a new 25% tariff on Venezuelan oil and gas imports imposed earlier this month, which Washington said targets Caracas but could also significantly impact China, Venezuela's largest oil buyer.
Chevron, which had been operating under a U.S. Treasury license allowing it to export around 250,000 barrels per day of Venezuelan crude, had not previously been affected by the new tariffs. However, the cancellation of these authorizations has disrupted that flow. At least two tankers had already loaded crude and may now have to return to port, while a third shipment was stopped before loading.
The U.S. Treasury had already rescinded licenses last month for several PDVSA partners, including Chevron, with a deadline of May 27 to complete operations. This latest action from PDVSA further complicates efforts to wind down business dealings under the tightened sanctions regime.
The government of Venezuelan President Nicolás Maduro condemned the U.S. measures, calling them part of an ongoing “economic war.” PDVSA and Chevron have not commented publicly on the cargo cancellations or whether the shipments will be rescheduled.
Though Chevron’s cargoes were initially shielded from the U.S. tariff due to its special license, the recent PDVSA decision has now placed its operations at risk, highlighting escalating geopolitical tensions and their direct impact on global oil markets.


Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Washington Post Publisher Will Lewis Steps Down After Layoffs
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



